Aerie Pharmaceuticals (NASDAQ:AERI) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Aerie Pharmaceuticals beat estimated earnings by 262.69%, reporting an EPS of $1.09 versus an estimate of $-0.67.
Revenue was up $89.98 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.1 which was followed by a 1.92% increase in the share price the next day.
Here's a look at Aerie Pharmaceuticals's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.62 | -0.64 | -0.68 | -0.73 |
| EPS Actual | -0.72 | -0.67 | -0.72 | -0.79 |
| Revenue Estimate | 28.89M | 26.28M | 22.78M | 22.36M |
| Revenue Actual | 29.31M | 27.18M | 22.97M | 24.68M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
